)
Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.
Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.
The Delhi NCR-based developer will use the funds to develop mid-income and ESG-aligned housing projects, repay Rs 470 crore of debt, and strengthen its balance sheet
International school boards IB, Cambridge, and WACE expand in India with teacher training, affordable programs, and growth beyond metros to Tier-2 and Tier-3 cities
The central drug regulator found one spurious cough syrup and 112 substandard formulations during its September 2025 checks, triggering detailed scrutiny
Premiums rise as AQI-assured homes attract eco-conscious buyers
Draft guidelines aim to align India's medtech software framework with global practices; industry seeks more clarity on AI/ML evaluation and algorithm change management
Delhi-NCR hospitals report a sharp spike in breathing-related cases as air quality turns 'severe' after Diwali; doctors expect numbers to rise in coming days
Festive cheer sustains housing market momentum amid broader headwinds
Health Ministry also mandates QR codes on vaccines and anti-cancer meds, eases sales licence norms for liquid antiseptics
M3M Group partners with luxury watchmaker Jacob & Co to build India's first branded residences in Noida, with an investment of Rs 2,100 crore and prices up to Rs 25 crore
Officials say ban comes with food brands not conforming with WHO guidelines, high OTC sales
Housing sales data shows regional imbalance with Southern markets gaining, even as North and West sees dip
CDSCO had earlier informed the global health body that none of the syrups were exported to other countries
Toxic cough syrups have once again proven fatal for children. This time, the tragedy has happened in India. Here's a look at why this sordid tale never seems to let up
The ministry has issued a draft notification proposing an amendment to add qualifications for inspectors and government analysts under Rule 18 of the Medical Device Rules (MDR), 2017
No state has fully complied with Corrective and Preventive Action (CAPA) guidelines, introduced for ensuring safety and maintaining standards in pharma products
A division bench comprising Justices C Hari Shankar and Ajay Digpaul upheld a March 2025 single-judge bench order that had denied Roche an injunction
The UK-based university, which got approval for its first Indian campus in Gujarat's Gift City, plans further expansion under India's National Education Policy 2020
With this, the state joins Maharashtra, Kerala and Tamil Nadu, who have already announced bans on the cough syrup
The highest-selling drug for the month was GlaxoSmithKline's Augmentin, an antibiotic, garnering revenues of ₹85 crore
Part-I of this three-part series dives into Delhi-NCR's SPR, Sohna, Dwarka Expressway, and Jewar Airport leading the charge